Pharma Articles
Renowned pharmaceutical firm executives and other experts from around the world write articles on current topics in the industry. The section of articles on the pharmaceutical sector focuses on contemporary and expanding challenges in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
FDA Drug Approval Pathways: Strategies for U.S. Pharmaceutical Companies
Getting a new medicine from the lab bench to a patients medicine cabinet is one of the longest costliest and most heavily scrutinized journeys in American business For every drug that reaches pharmacy shelves thousands of molecules never make it out of early testing The difference between the ones t...
Real-World Data and Real-World Evidence: Shaping the Future of Clinical Research
American healthcare generates a staggering volume of patient data every day electronic health records claims pharmacy fills laboratory results registries and increasingly sensor streams Congress recognised the opportunity in directing the FDA through the st Century Cures Act to build
Manufacturing Strategies for GLP-1s, Peptides, and High-Demand Biologics
Few product classes have humbled operational forecasting the way incretin therapies have Demand curves that boards approved as aggressive were overtaken within quarters Sites built for one modality found themselves supplying another And through it all the same question was asked in the same unhelpfu...
Decentralized Clinical Trials: A Strategic Shift for Faster Drug Development
Few operating ideas in drug development have traveled as far as fast in both directions as decentralization Necessity made it mainstream in Enthusiasm carried it into board presentations as a structural cost play Then the invoices arrived the savings proved elusive and a number of wellfunded progra...
The Future of mRNA Therapeutics: From Rare Diseases to Chronic Conditions
An mRNA therapeutic delivers a synthetic messenger RNA sequence into a patients cells so that the body itself manufactures a specific protein In a vaccine that protein is an antigen and the goal is an immune response In a therapeutic the protein is something the patient cannot make enough of or a re...
Strategic Evolution in Pharmaceutical Delivery: The Transition to Next-Generation Formulations
The pharmaceutical industry is changing quickly Formulation science has moved from a part of the work to a main point of focus as the ways of making medicine change from simple drugs to more complex biological treatments Formulation is much more than the way the medicine is given it is the main thin...
The Future of Pharma Partnerships: Strategic Alliances Driving Innovation
Beyond the Signing Ceremony Why Alliances Became the Industrys Growth EngineThere is a familiar photograph in pharmaceutical strategy two chief executives a signed term sheet a market capitalization moving
Next-Generation Fill-Finish Technologies for Sterile Drug Products
American pharmaceutical companies have spent a decade optimizing discovery clinical operations and commercial launch The step that actually puts a sterile product into a container has received a fraction of that attention and it is now the step most likely to determine whether a launch lands on sche...
Digital Transformation and Innovation in the U.S. Pharmaceutical Industry
Something fundamental has shifted inside American pharmaceutical companies over the past few years The clipboards are gone The manual logbooks have been replaced by sensors dashboards and predictive alerts that flag problems before they happen This shift didnt occur overnight but it has accelerated...
Mass Spectrometers: Principles, Instrumentation, Applications, and Future Perspectives
Mass spectrometry MS is one of the most powerful analytical technologies available in modern science It enables the identification characterization and quantification of compounds based on their masstocharge ratio mz Since its development in the early twentieth century mass spectrometry has evolved...
